Trial Profile
Phase IIa trial of dronabinol in patients with obstructive sleep apnoea
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Aug 2015
Price :
$35
*
At a glance
- Drugs Dronabinol (Primary)
- Indications Sleep apnoea syndrome
- Focus Proof of concept; Therapeutic Use
- Sponsors Cortex Pharmaceuticals; RespireRx Pharmaceuticals
- 21 Aug 2015 Primary endpoint "Apnea-hypopnea index" has been met according to a Cortex Pharmaceuticals media release.
- 01 Jul 2011 New trial record